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Abstract
Background: Understanding the irradiated area and dose correctly is important for the reirradiation of organs that
deform after irradiation, such as the liver. We investigated the spatial registration error using the deformable image
registration (DIR) software products MIM Maestro (MIM) and Velocity AI (Velocity).
Methods: Image registration of pretreatment computed tomography (CT) and posttreatment CT was performed in
24 patients with liver tumors. All the patients received proton beam therapy, and the follow-up period was 4–14
(median: 10) months. We performed DIR of the pretreatment CT and compared it with that of the posttreatment CT
by calculating the dislocation of metallic markers (implanted close to the tumors).
Results: The fiducial registration error was comparable in both products: 0.4–32.9 (9.3 ± 9.9) mm for MIM and 0.5–38.6
(11.0 ± 10.0) mm for Velocity, and correlated with the tumor diameter for MIM (r = 0.69, P = 0.002) and for Velocity
(r = 0.68, P = 0.0003). Regarding the enhancement effect, the fiducial registration error was 1.0–24.9 (7.4 ± 7.7) mm for
MIM and 0.3–29.6 (8.9 ± 7.2) mm for Velocity, which is shorter than that of plain CT (P = 0.04, for both).
Conclusions: The DIR performance of both MIM and Velocity is comparable with regard to the liver. The fiducial
registration error of DIR depends on the tumor diameter. Furthermore, contrast-enhanced CT improves the accuracy of
both MIM and Velocity.
Institutional review board approval: H28-102; July 14, 2016 approved.
Keywords: Deformable image registration, Rigid image registration, Liver, Proton beam therapy
Background
The various organs of the human body are often de-
formed by irradiation. Reirradiation is sometimes con-
ducted to treat new lesions that might occur. Before
reirradiation is performed, it is vital to confirm the
region irradiated by previous radiotherapy to avoid ex-
cess irradiation to the normal tissue as this could cause
severe adverse effects. Primary liver tumors tend to
recur inside the liver after treatment, and metastasis
from other organs also makes it highly possible that new
lesions will occur inside the liver. A substantial number
of patients, therefore, require reirradiation to treat recur-
rence of cancer in the liver [1].
Thus, image registration is a particularly important
issue for treating patients with liver tumors, even
though, since the advent of particle beam radiotherapy,
irradiated lesions are now well controlled [2–5]. To con-
duct image registration, an important problem must be
considered: after irradiation, the irradiated area includ-
ing the tumor is shrunk and the nonirradiated area is
shifted and sometimes enlarged or shrunk, thus causing
remarkable deformation of the liver in most patients [6].
This issue can be addressed by using deformable image
registration (DIR), and a number of software products
are now on the market. The use of DIR for applications
and assessment of previously delivered irradiation doses
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is clinically expected to protect the normal liver tissue
from receiving harmfully large doses of irradiation [7].
Several DIR algorithms exist, and DIR can be
broadly classified into two categories: (1) intensity-
based methods, which use a variety of image intensity
metrics such as the gray scale, and (2) feature-based
methods, which use specific image features such as
contours [8]. Transformation models include optical
flow-based equations [9], the “Demons” equation [10],
B-splines [11], and thin-plate splines [12]. In most
registration algorithms, the balance between image
similarity and accurate matching of the local features
on the one hand and deformation smoothness on the
other hand is crucial to accurately measure the de-
formation [13]. The technique for evaluating the
spatial accuracy of DIR involves landmark tracking
[14] or contour or structure comparisons [15].
In recent years, advanced software equipped with the
function of DIR has been developed for research pur-
poses, and some of them are also available for clinical
use. MIM Maestro (MIM Software Inc., OH, USA)
(MIM) and Velocity AI (Velocity Medical Solutions, GA,
USA) (Velocity) are the two most widely used in Japan
and worldwide 2 of the 3 most widely used commercially
available software products that can perform DIR and
assist radiotherapy planning. In MIM, the DIR algorithm
is intensity-based, free form cubic spline interpolation
with essentially unlimited degrees of freedom [13]. MIM
can dramatically deform the image, while, in cases with
little contrast, it might lead to unreasonable deformation
of the image. In Velocity, a B-spline deformable model is
used [13]. Velocity uses standardized image intensity
and has a smoothing and regularization function derived
from the B-spline method. Although both software prod-
ucts are relatively new, some reports on their features
and differences have been already been published. In
brief, these are that MIM has the advantage in terms of
small fields but sometimes produces registration error
because of image noise, and Velocity has the advantage
in terms of large fields. So far, there is no strong evi-
dence for which software is superior [8, 13, 16].
We examined the spatial accuracy of DIR of MIM and
Velocity after irradiation in the preliminary stage of
deformation of the dose distribution in reirradiated liver
tumors.
Methods
We retrospectively reviewed patients who had received
proton beam therapy (PBT) at our institute. All the
study procedures involving human participants were
conducted in accordance with the ethical standards of
the institutional research committee and with the 1964
Helsinki declaration and its later amendments or com-
parable ethical standards. All the treatments were
discussed at inhospital conferences, and informed con-
sent was obtained from all the individual participants in-
cluded in the study. The study received institutional
review board approval (H28-102). We selected those
patients who had a metallic material such as a fiducial
marker or surgical clip (herein called metallic marker)
already implanted very close to the liver tumor before
PBT. We examined 24 consecutive patients treated be-
tween 2009 and 2014 (20 men, 4 women; aged 52–84
years). The most common disease was hepatocellular
carcinoma (18 patients), followed by liver metastasis (5
patients) and intrahepatic bile duct carcinoma (1 pa-
tient). Fiducial markers for previous PBT were present
in 21 patients, and surgical clips, in 3 patients. At our
institute, abdominal computed tomography (CT) for
diagnosis is usually not taken after metallic marker im-
plantation, so these 21 patients had come to our hospital
to receive PBT for new lesions in the liver. Twenty-two
patients underwent irradiation for single lesions, and 2
patients, for 2 lesions. The total tumor diameter was 10-
69 (median: 35) mm. The tumor was located in the left
lobe in 5 patients, in the right lobe in 15 patients, and in
both lobes in 4 patients. The distance between the
tumor and the metallic marker was 5-33.7 (median:
12.0) mm. The total irradiation dose was 50-74 GyE in
22-37 fractions (Table 1).
Contrast-enhanced CT with the breath-holding tech-
nique was taken before and after treatment. The dur-
ation between PBT and posttreatment CT was 4-14
(median: 10) months. CT with a matrix resolution of
512*512 and a slice thickness of 5 mm was used. We
used both plain and contrast-enhanced CT in our image
analysis. For the patients who had dynamic contrast-
enhanced CT, we used portal venous-phase CT. We per-
formed rigid image registration (RIR) and then DIR of
the pretreatment CT images. During the registration
process, the priority area of calculation was manually
designated to cover the whole liver. The fiducial registra-
tion error was assessed by examining the dislocation of
the metallic marker from its position in the posttreat-
ment CT and that in the deformed pretreatment CT im-
ages. We used the point at which the metallic density
was the highest as the position of the metallic marker.
The same process was performed using MIM (version
6.5.2) and Velocity (version 3.1.0).
The fiducial registration errors of MIM and Velocity
were compared using both plain and contrast-enhanced
CT and a paired t test. The Pearson product moment
correlation was performed to examine the correlation
between the fiducial registration error of RIR and DIR.
Simple linear regression analysis was performed to
examine the correlation between tumor diameter and fi-
ducial registration error. Probability values below 0.05
were considered significant.
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Results
In the plain CT, the fiducial registration error was 0.4–
32.9 (9.3 ± 9.9) mm for MIM and 0.5–38.6 (11.0 ± 10.0)
mm for Velocity. The fiducial registration error was less
for MIM in 16 patients and for Velocity in 8 patients;
overall however, the results for both MIM and Velocity
were similar (P = 0.18). In the contrast-enhanced CT, the
fiducial registration errors for MIM (1.0–24.9 [7.4 ± 7.7]
mm) and Velocity (0.3–29.6 [8.9 ± 7.1] mm) were also
similar (P = 0.22) (Fig. 1a). As for the enhancement ef-
fect, the fiducial registration errors for MIM and Vel-
ocity were significantly shorter than they were in the
plain CT (P = 0.04, for both). (Fig. 1b).
With regard to the fiducial registration error, DIR was
significantly correlated with RIR for both MIM (r = 0.62,
P = 0.001) and Velocity (r = 0.9, P = 3.3×10-9) in the plain
CT (Fig. 2a). In the contrast-enhanced CT, DIR was also
significantly correlated with RIR for both MIM (r =0.66,
P = 0.0004) and Velocity (r = 0.84, P = 3.6 × 10-7). The fi-
ducial registration error was significantly correlated with
the tumor diameter for both MIM (r = 0.69, P = 0.002)
and Velocity (r =0.68, P =0.0003) in the plain CT. In the
contrast-enhanced CT, the fiducial registration error was
also significantly correlated with the tumor diameter for
both MIM (r =0.75, P = 2.8 × 10-5) and Velocity (r =0.63,
P = 9 × 10-5). The tumor diameter predicted to produce
a 10-mm fiducial registration error was 39.4 mm for
MIM and 35.5 mm for Velocity in the plain CT and 45.6
mm for MIM and 42 mm for Velocity in the contrast-
enhanced CT (Fig. 2b).
The tumor-marker distance did not differ according to
the classification of the tumor location. However, cases
in which the tumor in the right lobe had a trend toward
the tumor-marker distance became large (Table 2).
Figure 3 shows a case in which the fiducial registration
error was small and similar for both MIM and Velocity.
Figure 4 shows the cases that showed the biggest dis-
crepancies between MIM and Velocity in terms of the
fiducial registration error. Figure 5 shows the cases in
which the DIR results were greatly affected by the con-
trast enhancement effect. All the deformed images
showed slice levels that corresponded to the location of
the metallic marker on the posttreatment CT.
Discussion
We compared the capabilities of MIM and Velocity. At
first, we considered the advantages of MIM. Although
the fiducial registration error of DIR correlated with that
of RIR both for MIM and for Velocity, there were some
differences in the degree of fiducial registration error. As
shown in Fig. 2(a), the correlation coefficient for Vel-
ocity was 0.9, which is an extremely strong correlation,
whereas for MIM it was 0.62, which is only a moderate
correlation. Figure 4(a) shows the case with the largest
Fig. 1 Fiducial registration error. a MIM and Velocity. Left: plain CT; Right: contrast-enhanced CT. b Plain and contrast-enhanced CT. Left: MIM; Right: Velocity
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difference in fiducial registration error between Velocity
and MIM. The metallic marker could not be found in
the axial, coronal, or sagittal image in the RIR process of
both MIM and Velocity. However, during the DIR
process, MIM could correctly identify the location in
which the metallic marker was observed in any of the
directional images. In contrast, the DIR process of
Velocity shifted the location to a position in which the
metallic marker was not observed in any of the direc-
tional images. Yeo et al reported that the magnitude of
deformation has a much larger effect on the accuracy of
registration than does the complexity of deformation
[17]. Our results suggest that the DIR process in
Velocity seems to be more dependent on the RIR, while
MIM has a greater ability to modify during the process
of DIR. Next, we considered the advantages of Velocity.
As shown in Fig. 4(b) of an irradiated tumor in the right
lobe, MIM showed an unnaturally deformed low-density
tumor, especially in the coronal image, whereas Velocity
showed the natural shape of the tumor. Previous studies
have shown that MIM produces beautiful image similar-
ity but may produce nonphysical deformation fields,
while Velocity produces smooth, physically plausible
deformation fields [18]. It seems that MIM has higher
flexibility and causes excellent overall spatial accuracy;
although it tends to deform forcibly. This could
Table 2 Cases with large tumor marker distance
MIM (plain) MIM (enhance) Velocity (palin) Velocity (enhance)
T. M. D. (mm) T. L. T. D. (mm) Dis. (mm) Loc. T. D. (mm) Dis. (mm) Loc. T. D. (mm) Dis. (mm) Loc. T. D. (mm)
22.9 S8 30 20.0 S7/8 38 21.4 S8 60 20.4 S4/8 50
24.6 S6,S8 69 20.8 S6, S8 69 22.3 S4/8 50 29.6 S5/8 68
29.6 S5/8 68 24.9 S5/8 68 30.7 S6, S8 69
32.9 S8 60 38.6 S5/8 68 68
Abbreviations: T. M. D. tumor marker distance, T. L tumor location, T. D tumor diameter
Fig. 2 Correlation of the fiducial registration error. a RIR and DIR. Left: plain CT; Right: contrast-enhanced CT. b Tumor diameter and DIR. Left: plain
CT; Right: contrast-enhanced CT
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sometimes cause unreasonable DIR and diminish the
ability to transfer contours.
As shown in Fig. 1(a), although the fiducial registra-
tion errors of MIM and Velocity were similar overall,
they were not necessary closely correlated, and for
some patients either MIM or Velocity had a distinct
advantage. Some previous studies reported that it is
hard to decide which software is impartially superior
to others in terms of DIR accuracy [8, 13, 18]. Our
results also demonstrate that the superiority of DIR
accuracy for the liver varies by patient, making it dif-
ficult to state which software is better. It is generally
understood that DIR will work well with feature-rich
images in which there is little or no ambiguity
between corresponding points in the source and tar-
get images. The liver is one of the organs that have a
relatively homogeneous Hounsfield unit (HU) and a
lack of morphological characteristics. Therefore, one
important objective of this study was to determine
how well these software products can perform DIR in
low-contrast organs such as the liver. We analyzed
the portal vein phase image, which enhances a greater
number of vessels. As we expected, contrast-enhanced
CT could accomplish on average 1.9-mm less fiducial
registration error than could plain CT in MIM. More-
over, Velocity could also, on average, accomplish a
2.1-mm enhancement effect, as shown in Fig 1(b). In
addition, the enhancement effect could change the
deformation pattern. As shown in Fig. 5, the vector
went toward the right posterior direction in the plain
CT; by contrast, the vector circled in a clockwise
direction in the contrast-enhanced CT of MIM. Simi-
larly, in the plain CT, the vector moved slightly back-
wards only in the peripheral region of the liver,
whereas in the contrast-enhanced CT of Velocity, the
vector moved forward through most of the regions of
the liver. We are convinced that in the DIR of both
MIM and Velocity, enhancement-derived contrast not
only works toward spatial accuracy but also changes
the deformation pattern, such as the linear and
rotational directions.
We used a metallic marker to calculate the image
registration accuracy because it is difficult to measure
the registration error of the tumor itself and because
precise contouring of the whole liver by distinguish-
ing the liver from the porta hepatis is not completely
reproducible in each study. It is feasible to calculate
the fiducial registration error at multiple points in
each patient. However, in the daily clinical setting,
the number of implanted metallic markers is usually
1 or 2. Therefore, we selected only the patients whose
metallic materials were close to the tumor. In this
Fig. 3 A case with a small registration error for both MIM and Velocity. Proton beams at 72.6 GyE were delivered to the tumor in S4 7.8 months
before. The fiducial registration error was 1.8 mm in MIM and 1.9 mm in Velocity, the shortest among all the patients
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study, the metallic markers were implanted close to
the tumor, with a range of 5–33.7 (median: 12.0) mm.
Thus, we consider the metallic markers to act as sur-
rogates of the fiducial registration error in DIR. There
may be criticism that the high HU of the metallic
markers could have affected the image registration.
However, in all the patients, the metallic artifact was
so small when compared with the large volume of the
liver, and therefore, we think that the accuracy of the
image registration is seldom affected by the artifact.
Moreover, we routinely compare and conduct image
registration of CTs with tiny metallic markers already
implanted. Therefore, this analysis reflects the condi-
tions of the daily clinical setting, and we consider
that analysis using CT with implantation of tiny me-
tallic markers is clinically allowable.
Both MIM and Velocity have rapidly expanded the
market for such types of software, and new software
products have been manufactured or are planned for
manufacture to meet the demand for high-precision
radiotherapy. It is expected that several types of
commercial-based software products equipped with the
DIR function will be developed, not only for examin-
ation of previous radiotherapy planning, but also for use
in adaptive radiotherapy. In this study, we investigated
the registration error by using clinical data. However, it
is also important to investigate and validate the registra-
tion error by using phantoms. We are considering a
phantom study as the next step to prove the registration
error that we concluded in this clinical study.
Conclusion
For image registration of the liver, the DIR performances
of MIM and Velocity are similar overall. However, which
software is the better option varies according to the pa-
tient. The spatial accuracy of DIR depends on the
Fig. 4 Cases with large discrepancies in the registration error between MIM and Velocity. a Proton beams at 74 GyE were delivered to the tumor
in S3 14.2 months before. The fiducial registration error was 3 mm in MIM and 18 mm in Velocity, the largest discrepancy (Velocity-MIM) among
all the patients. b Proton beams at 72.6 GyE were delivered to the tumor in S7 8.9 months before. The fiducial registration error was 18.1 mm in
MIM and 4.7 mm in Velocity, the largest discrepancy (MIM-Velocity) among all the patients
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accuracy of RIR and also on the tumor diameter. Finally,
contrast-enhanced CT improves the accuracy of both
MIM and Velocity.
Abbreviations
CT: (Computed tomography): image used by computer-processed combina-
tions of many X-ray images; DIR: (Deformable image registration): image
registration technique with deformation; HU: (Hounsfield unit): A quantity
commonly used in CT to express CT numbers in a standardized and
convenient form; MIM: (MIM Maestro): name of software; PBT: (Proton beam
therapy): a type of radiotherapy using proton beams; RIR: (Rigid image
registration): image registration technique horizontally and rotationally
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